Although there is conflicting evidence regarding the role of Cdc42 dysregulation in cell and tissue aging, multiple studies have suggested that Cdc42 contributes to the development and progression of age-related pathologies, such as neurodegenerative and cardiovascular diseases, type 2 diabetes, and age-related joint and skeletal diseases [52]. Here, CDC42 is linked to bone disorder.